Literature DB >> 16235002

Chronic outpatient sildenafil therapy for pulmonary hypertension in a child after cardiac surgery.

C A Knoderer1, E S Ebenroth, J W Brown.   

Abstract

We report the case of a 14-month-old male with d-transposition of the great arteries, ventricular septal defect, and pulmonary hypertension successfully treated with long-term sildenafil following cardiac surgery. To our knowledge, this is the first published report of long-term sildenafil treatment in a child after corrective cardiac surgery.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16235002     DOI： 10.1007/s00246-005-0945-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  9 in total

1.  Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.

Authors:  A M Atz; D L Wessel
Journal:  Anesthesiology       Date:  1999-07       Impact factor: 7.892

Review 2.  Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Circulation       Date:  2003-07-15       Impact factor: 29.690

3.  Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises.

Authors:  Andrew M Atz; Amy K Lefler; David L Fairbrother; Walter E Uber; Scott M Bradley
Journal:  J Thorac Cardiovasc Surg       Date:  2002-09       Impact factor: 5.209

4.  Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.

Authors:  D Abrams; I Schulze-Neick; A G Magee
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

5.  Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.

Authors:  K Bando; M W Turrentine; T G Sharp; Y Sekine; T X Aufiero; K Sun; E Sekine; J W Brown
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

6.  Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study.

Authors:  O I Miller; S F Tang; A Keech; N B Pigott; E Beller; D S Celermajer
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

7.  Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.

Authors:  Ingram Schulze-Neick; Paulina Hartenstein; Jia Li; Brigitte Stiller; Nicole Nagdyman; Michael Hübler; Ghazwan Butrous; Andy Petros; Peter Lange; Andrew N Redington
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

8.  The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease.

Authors:  I A Russell; M S Zwass; J R Fineman; M Balea; K Rouine-Rapp; M Brook; F L Hanley; N H Silverman; M K Cahalan
Journal:  Anesth Analg       Date:  1998-07       Impact factor: 5.108

9.  How common is severe pulmonary hypertension after pediatric cardiac surgery?

Authors:  L Lindberg; A K Olsson; P Jögi; C Jonmarker
Journal:  J Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 5.209
  9 in total
  5 in total

Review 1.  Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.

Authors:  Leah Leibovitch; Ilan Matok; Gideon Paret
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.

Authors:  Gaetano Palma; Raffaele Giordano; Veronica Russolillo; Sabato Cioffi; Sergio Palumbo; Marco Mucerino; Vincenzo Poli; Carlo Vosa
Journal:  Tex Heart Inst J       Date:  2011

3.  Late-onset pulmonary arterial hypertension after a successful atrial or arterial switch procedure for transposition of the great arteries.

Authors:  Rachael Cordina; David Celermajer
Journal:  Pediatr Cardiol       Date:  2009-12-09       Impact factor: 1.655

Review 4.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

Review 5.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.